Alliance Pharmaceutical Corp Sample Contracts
Exhibit 4.1 OPTION AGREEMENT THIS OPTION AGREEMENT (this "AGREEMENT") dated as of this __ of June, 2001, is hereby entered into by and between [___________], a [__________] [LIMITED PARTNERSHIP] (the "SELLER"), Alliance Pharmaceutical Corp., a New...Option Agreement • June 26th, 2001 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "AGREEMENT") is made and entered into as of August 13, 1998, among Alliance Pharmaceutical Corp., a New York corporation (the "COMPANY"), Brown Simpson Strategic Growth Fund, L.P.,...Registration Rights Agreement • September 11th, 1998 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
ASSET PURCHASE AGREEMENT Dated June __, 2003 By and between Photogen Technologies, Inc.Asset Purchase Agreement • June 23rd, 2003 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
LICENSE AGREEMENT originally dated as of September 23, 1997 amended and restated in its entirety as of February 22, 2002License Agreement • May 15th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
WITNESSETH:Consulting Agreement • September 10th, 2001 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
RECITALSCommon Stock Purchase Agreement • November 19th, 1999 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
RECITALSSupply Agreement • February 14th, 2000 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Texas
Exhibit 10(ww) ALLIANCE/PFC SECURITY AGREEMENT THIS ALLIANCE/PFC SECURITY AGREEMENT (this "Security Agreement") is made as of this 19th day of May, 2000, by and between Alliance Pharmaceutical Corp., a New York corporation (the "Debtor"), and PFC...Security Agreement • September 1st, 2000 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
FORM OFWarrant Agreement • May 18th, 2000 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
COMMON STOCKUnderwriting Agreement • March 28th, 1996 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
ARTICLE 1 DEFINITIONSLicense Agreement • November 19th, 1999 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
LOGO] CREDIT AGREEMENTCredit Agreement • September 11th, 1998 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
INTELLECTUAL PROPERTY SECURITY AGREEMENT (Borrower as Grantor)Intellectual Property Security Agreement • September 28th, 1999 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
VOTING AGREEMENTVoting Agreement • November 9th, 2000 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Delaware
EXHIBIT 10(b) CONSULTING AGREEMENT THIS CONSULTING AGREEMENT made as of this 1st day of July, 2000 (the "Agreement") by and between Alliance Pharmaceutical GmbH, a German corporation (the "Company") and Jean Riess, whose address is Les Giaines, 06950...Consulting Agreement • February 14th, 2001 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances
08-02-99 COMMERCIAL SECURITY AGREEMENT PAGE 2 (CONTINUED)Commercial Security Agreement • September 28th, 1999 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
WITNESSETH:Consulting Agreement • May 15th, 2001 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
WITNESSETH THAT:Split Dollar Life Insurance Agreement • November 10th, 1999 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON EXERCISE HEREOF NOR ANY INTEREST OR PARTICIPATION HEREIN OR THEREIN MAY BE SOLD, ASSIGNED, PLEDGED, HYPOTHECATED, ENCUMBERED OR IN ANY OTHER MANNER TRANSFERRED OR DISPOSED OF EXCEPT IN COMPLIANCE...Warrant Agreement • September 28th, 1999 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Exhibit 4.2 SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 28th, 2000 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
FORM OF 6% CONVERTIBLE NOTE DUE 2005Convertible Note Agreement • February 14th, 2001 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances
RECITALSMarketing and Distribution Agreement • September 1st, 2000 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Illinois
CONFIDENTIAL TREATMENT REQUESTED EXHIBIT 10.78 CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 24(b)(2) OF THE SECURITIES AND EXCHANGE ACT OF 1934. CONFIDENTIAL TREATMENT REQUESTED IS REQUESTED AND IS NOTED WITH "[CONFIDENTIAL TREATMENT REQUESTED]." AN...Exclusivity Agreement • May 16th, 2005 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances
ANDMerger Agreement • November 20th, 1996 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Delaware
DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT BETWEEN PFC THERAPEUTICS, LLC AND BEIJING DOUBLE-CRANE PHARMACEUTICAL CO., LTD.Development, License and Supply Agreement • September 28th, 2005 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Exhibit 99.2(a) ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 19th, 1999 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
RECITALSManufacturing Agreement • September 1st, 2000 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Illinois
ContractWarrant Agreement • October 9th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR EXEMPTION FROM REGISTRATION UNDER THE FOREGOING LAWS.
Exhibit 10(a) SEVERANCE AGREEMENT AND RELEASE THIS SEVERANCE AGREEMENT AND RELEASE ("Agreement"), effective the 31st day of January, 2001, is entered into between ARTEMIOS B. VASSOS, M.D., F.A.C.P. ("Employee") and ALLIANCE PHARMACEUTICAL CORP., a New...Severance Agreement • May 15th, 2001 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
AGREEMENTConfidentiality Agreement • May 15th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Ohio
LIMITED LIABILITY COMPANY OPERATING AGREEMENT OF PFC THERAPEUTICS, LLCOperating Agreement • September 1st, 2000 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Delaware
LICENSE AGREEMENTLicense Agreement • February 27th, 1998 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
FORM OF SECURITY AGREEMENTSecurity Agreement • September 30th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
This SECURITY AGREEMENT, dated as of the 23rd day of July, 2002, made by Alliance Pharmaceutical Corp., a New York corporation (the "Grantor"), in favor of [ ], a [ ] and [ ], a [ ] (the "Secured Parties").
LICENSE AGREEMENT Executed this 28TH day of February, 1996, by and between ALLIANCE PHARMACEUTICAL CORP., a New York corporation (hereinafter referred to as "ALLIANCE") having its principal office at 3040 Science Park Road, San Diego, California 92121...License Agreement • March 28th, 1996 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
GENERAL SECURITY AGREEMENT (TANGIBLE AND INTANGIBLE PERSONAL PROPERTY) IMPERIAL BANK Member FDIC This Agreement is executed on June 17, 1998, by ALLIANCE PHARMACEUTICAL CORP. a New York corporation (hereinafter called "Obligor"). In consideration of...General Security Agreement • September 11th, 1998 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California